A review of all‐vanadium redox flow battery durability: Degradation mechanisms and mitigation strategies

The all‐vanadium redox flow battery (VRFB) is emerging as a promising technology for large‐scale energy storage systems due to its scalability and flexibility, high round‐trip efficiency, long durability, and little environmental impact. As the degradation rate of the VRFB components is relatively low, less attention has been paid in terms of VRFB durability in comparison with studies on performance improvement and cost reduction. This paper reviews publications on performance degradation mechanisms and mitigation strategies for VRFBs in an attempt to achieve a systematic understanding of VRFB durability. Durability studies of individual VRFB components, including electrolyte, membrane, electrode, and bipolar plate, are introduced. Various degradation mechanisms at both cell and component levels are examined. Following these, applicable strategies for mitigating degradation of each component are compiled. In addition, this paper summarizes various diagnostic tools to evaluate component degradation, followed by accelerated stress tests and models for aging prediction that can help reduce the duration and cost associated with real lifetime tests. Finally, future research areas on the degradation and accelerated lifetime testing for VRFBs are proposed

Improving the Rectangle Attack on GIFT-64

GIFT is a family of lightweight block ciphers based on SPN structure and composed of two versions named GIFT-64 and GIFT-128. In this paper, we reevaluate the security of GIFT-64 against the rectangle attack under the related-key setting. Investigating the previous rectangle key recovery attack on GIFT-64, we obtain the core idea of improving the attack——trading off the time complexity of each attack phase. We flexibly guess part of the involved subkey bits to balance the time cost of each phase so that the overall time complexity of the attack is reduced. Moreover, the reused subkey bits are identified according to the linear key schedule of GIFT-64 and bring additional advantages for our attacks. Furthermore, we incorporate the above ideas and propose a dedicated MILP model for finding the best rectangle key recovery attack on GIFT-64. As a result, we get the improved rectangle attacks on 26-round GIFT-64, which are the best attacks on it in terms of time complexity so far

Optimizing Rectangle Attacks: A Unified and Generic Framework for Key Recovery

The rectangle attack has shown to be a very powerful form of cryptanalysis against block ciphers. Given a rectangle distinguisher, one expects to mount key recovery attacks as efficiently as possible. In the literature, there have been four algorithms for rectangle key recovery attacks. However, their performance vary from case to case. Besides, numerous are the applications where the attacks lack optimality. In this paper, we investigate the rectangle key recovery in depth and propose a unified and generic key recovery algorithm, which supports any possible attacking parameters. Notably, it not only covers the four previous rectangle key recovery algorithms, but also unveils five types of new attacks which were missed previously. Along with the new key recovery algorithm, we propose a framework for automatically finding the best attacking parameters, with which the time complexity of the rectangle attack will be minimized using the new algorithm. To demonstrate the efficiency of the new key recovery algorithm, we apply it to Serpent, CRAFT, SKINNY and Deoxys-BC-256 based on existing distinguishers and obtain a series of improved rectangle attacks

Use of the 2A Peptide for Generation of Multi-Transgenic Pigs through a Single Round of Nuclear Transfer

Multiple genetic modifications in pigs can essentially benefit research on agriculture, human disease and xenotransplantation. Most multi-transgenic pigs have been produced by complex and time-consuming breeding programs using multiple single-transgenic pigs. This study explored the feasibility of producing multi-transgenic pigs using the viral 2A peptide in the light of previous research indicating that it can be utilized for multi-gene transfer in gene therapy and somatic cell reprogramming. A 2A peptide-based double-promoter expression vector that mediated the expression of four fluorescent proteins was constructed and transfected into primary porcine fetal fibroblasts. Cell colonies (54.3%) formed under G418 selection co-expressed the four fluorescent proteins at uniformly high levels. The reconstructed embryos, which were obtained by somatic cell nuclear transfer and confirmed to express the four fluorescent proteins evenly, were transplanted into seven recipient gilts. Eleven piglets were delivered by two gilts, and seven of them co-expressed the four fluorescent proteins at equivalently high levels in various tissues. The fluorescence intensities were directly observed at the nose, hoof and tongue using goggles. The results suggest that the strategy of combining the 2A peptide and double promoters efficiently mediates the co-expression of the four fluorescent proteins in pigs and is hence a promising methodology to generate multi-transgenic pigs by a single nuclear transfer

miR-21 Protects Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Preventing Epithelial Cell Apoptosis and Inhibiting Dendritic Cell Maturation

Renal tubular injury and innate immune responses induced by hypoxia contribute to acute kidney injury. Accumulating evidence suggests that miR-21 overexpression protects against kidney ischemia injury. Additionally, miR-21 emerges as a key inhibitor in dendritic cell maturation. Thus, we hypothesized that miR-21 protects the kidney from IR injury by suppressing epithelial cell damage and inflammatory reaction. In this study, we investigated effects of miR-21 and its signaling pathways (PTEN/AKT/mTOR/HIF, PDCD4/NFκ-B) on kidney ischemia/reperfusion (IR) injury in vitro and in vivo. The results revealed that IR increased miR-21, HIF1α, and 2α expression in vivo and in vitro. MiR-21 interacted with HIF1α and 2α through the PTEN/AKT/mTOR pathway. Moreover, inhibition of miR-21 activated PDCD4/NFκ-B pathways, which are critical for dendritic cell maturation. Renal IR triggers local inflammation by inducing the dendritic cell maturation and promoting the secretion of IL-12, IL-6, and TNF-α cytokines. Knockdown of miR-21 intensified the effect of IR on tubular epithelial cell apoptosis and dendritic cell maturation. Our results suggested that IR-inducible miR-21 protects epithelial cells from IR injury via a feedback interaction with HIF (PTEN/AKT/mTOR/HIF/miR-21) and by inhibiting maturation of DCs through the PDCD4/NF-κB pathway. These findings highlight new therapeutic opportunities in AKI

Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis

Hyperprogressive disease (HPD) is a recently acknowledged pattern of rapid tumor progression after the initiation of immune checkpoint inhibitors. HPD has been observed across various types of tumors and has been associated with poor survival. We performed a meta-analysis to identify baseline (i.e., prior to programmed cell death 1 [PD-1, PDCD1] / programmed cell death 1 ligand 1 [PD-L1, CD274] inhibitor therapy) patient factors associated with risks of developing HPD during PD-1/PD-L1 inhibitor therapy. We searched eight databases until 6 June 2019. We calculated the summary odds ratio (OR) and its 95% confidence interval (CI) using the random-effects model and explored between-study heterogeneity and small-study effects. A total of nine articles was eligible (217 HPD cases, 1519 cancer patients) for meta-analysis. There was no standard definition of HPD, and the incidence of HPD ranged from 1 to 30%. We identified twenty-three baseline patient factors, of which five factors were statistically significantly associated with HPD. These were serum lactate dehydrogenase (LDH) above the upper normal limit (OR = 1.89, 95% CI = 1.02-3.49, p = 0.043), more than two metastatic sites (OR = 1.86, 1.34-2.57, p < 0.001), liver metastases (OR = 3.33, 2.07-5.34, p < 0.001), Royal Marsden Hospital prognostic score of 2 or above (OR = 3.33, 1.96-5.66, p < 0.001), and positive PD-L1 expression status that was inversely correlated with HPD (OR = 0.60, 0.36-0.99, p = 0.044). Between-study heterogeneity was low. Evidence of small-study effect was found in one association (PD-L1 expression). Subset analyses of patients with non-small cell lung cancer showed similar results. Future studies are warranted to identify underlying molecular mechanisms and to test their roles as predictive biomarkers of HPD